Skip to Content

Medications for Acute Lymphoblastic Leukemia

Cancer of a specific type of white blood cell called lymphocytes.

Drugs used to treat Acute Lymphoblastic Leukemia

The following list of medications are in some way related to, or used in the treatment of this condition.

Drug name Rating Reviews Activity ? Rx/OTC Pregnancy CSA Alcohol
Adriamycin Rate Add review
Rx D N

Generic name: doxorubicin systemic

Drug class: antibiotics/antineoplastics

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Arranon Rate Add review
Rx D N

Generic name: nelarabine systemic

Drug class: antimetabolites

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

asparaginase erwinia chrysanthemi Rate Add review
Rx C N X

Generic name: asparaginase erwinia chrysanthemi systemic

Brand name:  Erwinaze

Drug class: miscellaneous antineoplastics

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

Asparlas Rate Add review
Rx N X

Generic name: calaspargase pegol systemic

Drug class: miscellaneous antineoplastics

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Besponsa Rate Add review
Rx N

Generic name: inotuzumab ozogamicin systemic

Drug class: miscellaneous antineoplastics

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

blinatumomab Rate Add review
Rx C N

Generic name: blinatumomab systemic

Brand name:  Blincyto

Drug class: miscellaneous antineoplastics

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

Blincyto Rate Add review
Rx C N

Generic name: blinatumomab systemic

Drug class: miscellaneous antineoplastics

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

calaspargase pegol Rate Add review
Rx N X

Generic name: calaspargase pegol systemic

Brand name:  Asparlas

Drug class: miscellaneous antineoplastics

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

clofarabine Rate Add review
Rx D N X

Generic name: clofarabine systemic

Brand name:  Clolar

Drug class: antimetabolites

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

Clolar Rate Add review
Rx D N X

Generic name: clofarabine systemic

Drug class: antimetabolites

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

dasatinib 10 1 review
Rx D N

Generic name: dasatinib systemic

Brand name:  Sprycel

Drug class: BCR-ABL tyrosine kinase inhibitors

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

doxorubicin Rate Add review
Rx D N

Generic name: doxorubicin systemic

Brand name:  Adriamycin

Drug class: antibiotics/antineoplastics

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

Erwinaze Rate Add review
Rx C N X

Generic name: asparaginase erwinia chrysanthemi systemic

Drug class: miscellaneous antineoplastics

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Gleevec 10 1 review
Rx D N

Generic name: imatinib systemic

Drug class: BCR-ABL tyrosine kinase inhibitors

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Iclusig 1.0 1 review
Rx D N

Generic name: ponatinib systemic

Drug class: multikinase inhibitors, BCR-ABL tyrosine kinase inhibitors, VEGF/VEGFR inhibitors

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

imatinib 10 1 review
Rx D N

Generic name: imatinib systemic

Brand name:  Gleevec

Drug class: BCR-ABL tyrosine kinase inhibitors

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

inotuzumab ozogamicin Rate Add review
Rx N

Generic name: inotuzumab ozogamicin systemic

Brand name:  Besponsa

Drug class: miscellaneous antineoplastics

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

Kymriah Rate Add review
Rx N

Generic name: tisagenlecleucel systemic

Drug class: miscellaneous antineoplastics

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Marqibo Rate Add review
Rx D N

Generic name: vincristine liposome systemic

Drug class: mitotic inhibitors

For consumers: dosage, interactions, side effects

mercaptopurine Rate Add review
Rx D N

Generic name: mercaptopurine systemic

Brand names:  Purinethol, Purixan

Drug class: antimetabolites

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

methotrexate Rate Add review
Rx X N X

Generic name: methotrexate systemic

Brand names:  Trexall, Xatmep

Drug class: antimetabolites, antirheumatics, antipsoriatics, other immunosuppressants

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

nelarabine Rate Add review
Rx D N

Generic name: nelarabine systemic

Brand name:  Arranon

Drug class: antimetabolites

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

Oncaspar Rate Add review
Rx C N X

Generic name: pegaspargase systemic

Drug class: miscellaneous antineoplastics

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

pegaspargase Rate Add review
Rx C N X

Generic name: pegaspargase systemic

Brand name:  Oncaspar

Drug class: miscellaneous antineoplastics

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

ponatinib 1.0 1 review
Rx D N

Generic name: ponatinib systemic

Brand name:  Iclusig

Drug class: multikinase inhibitors, BCR-ABL tyrosine kinase inhibitors, VEGF/VEGFR inhibitors

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

Learn more about Acute Lymphoblastic Leukemia

IBM Watson Micromedex

Legend

Rating For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).
Activity Activity is based on recent site visitor activity relative to other medications in the list.
Rx Prescription Only.
OTC Over the Counter.
Rx/OTC Prescription or Over the Counter.
Off-label This medication may not be approved by the FDA for the treatment of this condition.
EUA An Emergency Use Authorization (EUA) allows the FDA to authorize unapproved medical products or unapproved uses of approved medical products to be used in a declared public health emergency when there are no adequate, approved, and available alternatives.
Pregnancy Category
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act (CSA) Schedule
M The drug has multiple schedules. The schedule may depend on the exact dosage form or strength of the medication.
U CSA Schedule is unknown.
N Is not subject to the Controlled Substances Act.
1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
Alcohol
X Interacts with Alcohol.

Browse Treatment Options

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.